Obama's deal with drug firms survives
Washington Post, September 25, 2009
Democratic senators tried unsuccessfully to override a deal the drug industry struck months ago with the Obama White House and Senate Finance Committee Chairman Max Baucus (D-Mont.). If the deal fell apart, industry allies warned, the drug lobby could pivot from health reform cheerleader to committed opponent armed with a $125 million war chest. It also foreshadowed battles to come as Democrats in both the House and Senate vowed anew to seek larger concessions from an industry that spent $92 million in lobbying in the first half of this year.
Most Viewed
Most Emailed
- Primary Care Docs Average More Hospital Revenue Than Specialists
- How Chargemaster Data May Affect Hospital Revenue
- House Lawmakers Grill CMS Over Health Exchange Navigators
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- ED Physicians Key to Half of Hospital Admissions
- Insurer's App Aims to Lower Healthcare Costs, Securely
- Fortunately, Angelina Jolie Isn't On Medicare
- Don't Let Nurses Sink Your Bottom Line
- Q&A: Catholic Health Initiatives' New Senior VP for Capital Finance
